炎症・再生
Online ISSN : 1880-5795
Print ISSN : 1346-8022
ISSN-L : 1346-8022
膠原病における進歩と今後の展望―全身性エリテマトーデス患者自己抗体産生細胞のアポトーシス回避機構の解析とその是正―
鈴木 登
著者情報
ジャーナル フリー

2001 年 21 巻 6 号 p. 635-638

詳細
抄録
Fas and Fas ligand (FasL) have been assigned a pivotal role for the development and maintenance of peripheral tolerance. Mice having defects in Fas and FasL develop lupus like symptoms. In this study, we have studied FasL expression of peripheral blood lymphocytes in patients with systemic lupus erythematosus (SLE) . Expression of FasL was not or very weakly detected in the freshly isolated PBMC in normal individuals. In contrast, freshly SLE PBMC exhibits enhanced expression of FasL withoutin vitrostimulation. Not only purified T cells but also purified B cells expressed FasL on their cell surface spontaneously in patients with SLE. Anti-DNA antibody secreting B cells were purified by using biotin labeled DNA and streptavidin-bead, and the freshly isolated anti-DNA autoantibody secreting B cells express FasL spontaneously. Thus autoreactive B lymphocytes that aberrantly express FasL would kill Fas+ immunoregulatory T lymphocytes. The aberrantly expressed FasL on B cells would, at least partly, facilitate escape of the autoreactive B cells from immune tolerance system, and may contribute sustained secretion of autoantibodies in patients with SLE.
著者関連情報
© 日本炎症・再生医学会
前の記事 次の記事
feedback
Top